These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12176438)

  • 1. 15-Deoxyspergualin protects the islet graft from macrophage-mediated injury.
    Juang JH; Hsu BR; Kuo CH
    Transplant Proc; 2002 Aug; 34(5):1458-9. PubMed ID: 12176438
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended functional survival of murine islet allografts with 15-deoxyspergualin.
    Kaufman DB; Field MJ; Gruber SA; Farney AC; Stephanian E; Gores PF; Sutherland DE
    Transplant Proc; 1992 Jun; 24(3):1045-7. PubMed ID: 1604510
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 15-deoxyspergualin in islet xenograft rejection.
    Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
    [No Abstract]   [Full Text] [Related]  

  • 4. Fish-to-mouse islet xenograft survival is markedly prolonged by 15-deoxyspergualin.
    Wright JR; Kearns H
    Transplant Proc; 1995 Feb; 27(1):294-5. PubMed ID: 7879009
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation.
    Aomatsu Y; Nakajima Y; Iwata H; Amemiya H; Kanehiro H; Hisanaga M; Yoshimura A; Kido K; Taki J; Horikawa M
    Transplant Proc; 1995 Feb; 27(1):292-3. PubMed ID: 7879008
    [No Abstract]   [Full Text] [Related]  

  • 6. Xenotransplantation of pig pancreatic islets to rat using 15-deoxyspergualin monotherapy.
    Jindal RM; Soltys K; Yost F; Beer E; Tepper MA; Cho SI
    Transplant Proc; 1994 Jun; 26(3):1108-9. PubMed ID: 8029848
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
    Hisanaga M; Nakajima Y; Yabuuchi H; Nakano H
    Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistological study of islet xenograft rejection in immunosuppressed recipients.
    Andereggen E; Bühler L; Fournier B; Deng S; Bubloz C; Morel P
    Transplant Proc; 1996 Apr; 28(2):826-8. PubMed ID: 8623420
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic interaction of 15-deoxyspergualin and cyclosporine to prolong the survival of rat islet allografts.
    Gores PF; Field JF; Sutherland DE; Chou TC
    Transplant Proc; 1994 Apr; 26(2):745. PubMed ID: 8171638
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of islet and pancreas graft survival in spontaneous diabetic BB/W rats by perioperative cyclosporin or 15-deoxyspergualin therapy.
    von Specht BU; Dibelius A; Königsberger H; Lodde G; Roth H; Permanetter W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):965-7. PubMed ID: 2495636
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
    Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
    Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of primary nonfunction of xenograft islets.
    Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT
    Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862
    [No Abstract]   [Full Text] [Related]  

  • 13. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts.
    Henretta J; Pittman K; McFadden T; Thomas J; Thomas F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):412-3. PubMed ID: 8438358
    [No Abstract]   [Full Text] [Related]  

  • 14. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
    Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mouse islet isografts from nonspecific inflammatory damage by recipient treatment with nicotinamide and 15-deoxyspergualin.
    Kenmochi T; Miyamoto M; Mullen Y
    Cell Transplant; 1996; 5(1):41-7. PubMed ID: 8665075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of 15-deoxyspergualin in xenografting islets of Langerhans.
    Nakajima Y; Yoshimura A; Kanehiro H; Aomatsu Y; Nakano H
    Transplant Proc; 1994 Jun; 26(3):1093-4. PubMed ID: 8029842
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of islet xenograft survival with combined treatment of 15-deoxyspergualin or cyclosporine and anti-CD4 monoclonal antibody.
    Lu X; Borel JF
    Transplant Proc; 1995 Feb; 27(1):298-9. PubMed ID: 7879010
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
    Rastellini C; Cicalese L; Leach R; Braun M; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):646-7. PubMed ID: 10083278
    [No Abstract]   [Full Text] [Related]  

  • 19. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts.
    Thomas F; Pittman K; Ljung T; Cekada E
    Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rapamycin on islet xenograft survival.
    Lu X; Schuurman HJ; Borel JF
    Transplant Proc; 1994 Jun; 26(3):1128-9. PubMed ID: 8029857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.